antiprimod has been researched along with bortezomib in 2 studies
Studies (antiprimod) | Trials (antiprimod) | Recent Studies (post-2010) (antiprimod) | Studies (bortezomib) | Trials (bortezomib) | Recent Studies (post-2010) (bortezomib) |
---|---|---|---|---|---|
32 | 0 | 11 | 6,868 | 860 | 4,753 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Dong, W; Qian, J; Sun, L; Wang, M; Yang, J; Yi, Q; Zhang, L | 1 |
2 other study(ies) available for antiprimod and bortezomib
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Combination of atiprimod and the proteasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Inducing Factor; Blotting, Western; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Lymphoma, Mantle-Cell; Male; Mice; Mice, Inbred NOD; Mice, SCID; Pyrazines; Spiro Compounds; Survival Rate | 2012 |